Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Affymetrix SNP array data for acute leukemias with a 14q32/BCL11B rearrangement

ABSTRACT: Affymetrix SNP array data for acute leukemias with a 14q32/BCL11B rearrangement

PROVIDER: PRJNA680304 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Affymetrix SNP array data for acute leukemias with a 14q32/BCL11B rearrangement

Project description:This study identified a cytogenetic-molecular entity, we named BCL11B-R, that showed a typical constellation of genomic features, namely BCL11B activation via chromosome translocations at 14q32, a distinct transcriptome profile, and FLT3 mutations.

2021-09-05 | GSE162000 | GEO

RNA-seq analysis of 12 cases with BCL11B rearrangement

2021-09-05 | GSE162280 | GEO

14q32 recombinations deregulating BCL11B mark a distinct Mixed Phenotype Leukemia

Project description:14q32 recombinations deregulating BCL11B mark a distinct Mixed Phenotype Leukemia

| PRJNA681239 | ENA

Targeted Sequencing of BCL11B-R patients

2021-09-05 | GSE162282 | GEO

RNA-seq analysis of 12 cases with BCL11B rearrangement

Project description:RNA-seq analysis of 12 cases with BCL11B rearrangement

| PRJNA681241 | ENA

Affymetrix SNP array data for Myeloid Neoplasms with PDGFRB Rearrangement

Project description:Affymetrix SNP array data for Myeloid Neoplasms with PDGFRB Rearrangement

| PRJNA757780 | ENA

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [HiChIP]

Project description:Hijacking of primitive hematopoietic enhancers, or generation of a neo-enhancer by genomic amplification, results in deregulation of BCL11B as the defining feature of a subset of T/myeloid leukemia. We report H3K27ac and BCL11B binding in these Leukemias.

2021-05-19 | GSE165207 | GEO

Affymetrix SNP array data for NUP98 rearranged acute leukemias

Project description:We assessed lineage involvement by NUP98 translocations in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and T-cell acute lymphoblastic leukemia (T-ALL). Single cell analysis by FICTION (Fluorescence Immunophenotype and Interphase Cytogenetics as a Tool for Investigation of Neoplasms) showed that NUP98-translocations with various partners, i.e. NSD1, DDX10, RAP1GDS1, and LNP1, always affected a CD34+/CD133+ hematopoietic precursor. Interestingly, in MDS/AML myelomonocytes, erythroid cells, B- and T- lymphocytes belonged to the abnormal clone, while in T-ALL only CD7+/CD3+ cells were involved. The partner did not appear to play a major role in determining the leukemia phenotype as shown in AML and T-ALL with the same NUP98-RAP1GDS1 fusion. Additional hits, namely mutations of FLT3 and CEBPA in MDS/AML and mutation of NOTCH1 plus MYB duplication in T-ALL, were identified in leukemias with, respectively, myeloid or T-lymphoid phenotype. Affymetrix SNP arrays were performed according to the manufacturer's directions on DNA extracted from cryopreserved diagnostic bone marrow or peripheral blood samples. Copy number and Copy neutral LOH analysis of with Affymetrix Cytogenetic 2.7 and Cytoscan HD SNP arrays was performed on 6 NUP98 rearranged leukemias.

2014-08-26 | E-GEOD-60733 | biostudies-arrayexpress

Affymetrix SNP array data for NUP98 rearranged acute leukemias

2014-08-26 | GSE60733 | GEO

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [ChIP-Seq]

2021-05-19 | GSE165016 | GEO